New diabetes clinical trial: Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab

Published on: 2026-04-09T04:00:00Z
Conditions: Diabetic Retinopathy (DR); Diabetic Macular Edema (DME)
Interventions: Drug: Faricimab; Drug: Biosimilar ranibizumab
Sponsors: Osijek University Hospital
Recruiting
https://ift.tt/OqfY0kC